CDEK by Data4ThePeople

Sign in Sign up

← All organizations

Grupo Cooperativo de Estudio y Tratamiento de las Leucemias Agudas y Mielodisplasias

Academic/HospitalWebsite ↗

Also known as: Grupo Cooperativo de Estudio y Tratamiento de las Leucemias Agudas y Mielodisplasias

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Last known activity

Aug 5, 2025

Timeline

1980s

Jan 1, 1988
Grupo Cooperativo de Estudio y Tratamiento de las Leucemias Agudas y Mielodisplasias— Founded

Drugs by trial phase (12 distinct, 8 trials)

Phase 3 (1 own, 0 via acquisition)

venetoclax

Phase 2 (10 own, 0 via acquisition)

Other trials (1 own, 0 via acquisition)

Filgrastim

Indications

Studied for

Recent trials (8)

NCT07075016CollaboratorPhase 3Aug 5, 2025
NCT06668558Lead sponsorPhase 2Oct 31, 2024
NCT01700413Lead sponsorPhase 2Oct 1, 2012
NCT04687098Lead sponsorN/AFeb 1, 2012
NCT01193400CollaboratorPhase 2Sep 1, 2010
NCT01698879Lead sponsorPhase 2Oct 1, 2009
NCT01723657Lead sponsorPhase 2Oct 1, 2003
NCT01716793Lead sponsorPhase 2Sep 1, 1998

Details

Founded: Barcelona, ES Jan 1, 1988
Last known activity: Aug 5, 2025